Polyactose and Bile Acid Excretion in Rats

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Polyactose and Bile Acid Excretion in Rats

Published Date

2019

Publisher

Type

Report

Abstract

In America, cardiovascular disease is the leading cause of death in adults. In addition, people with hyperlipidemia, or high lipid concentration in the blood - including cholesterol, are twice as likely to develop CVD as people without hyperlipidemia. Statins are a class of medications that reduce total cholesterol levels and reduce risks of CVD (1). However, statins can have serious side effects such as: muscle pain, liver damage, increase in blood glucose levels, and memory loss of confusion. In rare cases, statins may induce rhabdomyolysis, which can cause severe muscle pain, liver damage, kidney failure and death (2). Thus, there is continued interest in non-pharmacological approaches to lowering blood cholesterol concentrations. Prebiotics, a type of dietary fiber that is indigestible by mammals, may be another way to reduce cholesterol without the adverse effects of statins or other medications. Prebiotics are defined to produce a positive change in the microflora of an organism and are beneficial to the host (3). This project aims to study polylactose, a newly synthesized oligosaccharide that has a potential to be a prebiotic. A recently conducted study in rats, using a high-fat diet as a background diet, found that feeding polylactose lowered liver cholesterol concentration. The mechanism by which polylactose imparts this effect is unknown. The purpose of this project was to examine one potential mechanism by which polylactose may lower liver cholesterol in rats, specifically, whether polylactose increases bile acid excretion. As bile acids are synthesized from cholesterol, and an increased loss of bile acids has the potential to lower cholesterol by diverting it into bile acid synthesis. Results of this project indicate that the high fat polylactose fed rats indeed showed lower liver cholesterol levels, indicating that polylactose has a potential to be a dietary cholesterol-lowering agent. However, the polylactose diet fed group did not result in increased bile acid excretion. This suggests that polylactose lowers liver cholesterol by a mechanism different from the study objective - excreting bile acids. Therefore, further studies should be conducted to determine the mechanism by which polylactose acts as a dietary cholesterol-lowering agent in rats.

Description

Faculty Advisor: Dan Gallaher, PhD

Related to

Replaces

License

Series/Report Number

Funding information

This research was supported by the Undergraduate Research Opportunities Program (UROP).

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Wolniewicz, Emily; Abernathy, Breann; Gallaher, Dan. (2019). Polyactose and Bile Acid Excretion in Rats. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/208713.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.